Skip to main navigation

Client IR Menu

  • Company
  • Technology
  • Therapeutic Areas
  • Pipeline
  • Partnering
  • Careers
  • News
  • Investors
  • Contact Us

Client IR Menu

  • Company
  • Technology
  • Therapeutic Areas
  • Pipeline
  • Partnering
  • Careers
  • News
  • Investors
  • Contact Us
Xeris Xeris
Xeris Xeris

Client IR Menu

  • Company
    • Executive Team
    • Board of Directors
  • Technology
    • XeriJect™
    • XeriSol™
  • Therapeutic Areas
    • Hypoglycemia
    • Acute Repetitive Seizures (ARS)
    • Congenital Hyperinsulinism (CHI)
    • Exercise-induced Hypoglycemia
    • Hypoglycemia-Associated Autonomic Failure (HAAF)
    • Post-Bariatric Hypoglycemia (PBH)
    • Type 1/Type 2 Blood Sugar Control
  • Pipeline
    • Expanded Access
  • Partnering
  • Careers
  • News
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Management
      • Board of Directors
      • Documents & Charters
    • SEC Filings
    • Investor Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Contact Us

Stock Quote & Chart

Investor Relations

  • MENU
  • Overview
  • News Releases
  • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Corporate Governance
    • Management
    • Board of Directors
    • Documents & Charters
  • SEC Filings
  • Analyst Coverage
  • Investor Resources
    • FAQs
    • Email Alerts
    • Contact IR

Stock Quote & Chart

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Copyright West LLC. Minimum 15 minutes delayed.

 

Email Alerts

 

FAQs

 

Contact US

  • Terms of Use/Privacy Policy
  • Financial Conflict of Interest Policy

All rights reserved © 2018 Xeris Pharmaceuticals, Inc.